Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Price

Showing results (81-90 of 195) with videos related to

Pageof 20
Sort By:
Journal of Child and Adolescent Psychopharmacology|June 5, 1999
Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three casesC N Epperson, D Fasula, S Wasylink, et al.
The American Journal of Psychiatry|September 1, 1997
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorderL C Barr, W K Goodman, A Anand, et al.
Life Sciences|January 1, 1989
Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjectsP L Delgado, D S Charney, L H Price, et al.
Biological Psychiatry|May 1, 1997
Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjectsL C Barr, G R Heninger, W Goodman, et al.
Biological Psychiatry|December 1, 1995
Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind studyA Cappiello, C J McDougle, R T Malison, et al.
The American Journal of Drug and Alcohol Abuse|January 1, 1992
Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?J H Krystal, L H Price, C Opsahl, et al.
Archives of General Psychiatry|August 2, 2000
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorderC J McDougle, C N Epperson, G H Pelton, et al.
The Journal of Clinical Psychiatry|March 13, 1999
Mirtazapine augmentation in the treatment of refractory depressionL L Carpenter, Z Jocic, J M Hall, et al.
Journal of Child and Adolescent Psychopharmacology|July 1, 1997
Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigationE S Brodkin, C J McDougle, S T Naylor, et al.
Journal of Clinical Psychopharmacology|February 24, 1998
Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotoninM Narayan, G Anderson, J Cellar, et al.
Pageof 20

Showing results (81-90 of 195) with videos related to

Sort By:
Pageof 20
Journal of Child and Adolescent Psychopharmacology|June 5, 1999
Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three casesC N Epperson, D Fasula, S Wasylink, et al.
The American Journal of Psychiatry|September 1, 1997
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorderL C Barr, W K Goodman, A Anand, et al.
Life Sciences|January 1, 1989
Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjectsP L Delgado, D S Charney, L H Price, et al.
Biological Psychiatry|May 1, 1997
Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjectsL C Barr, G R Heninger, W Goodman, et al.
Biological Psychiatry|December 1, 1995
Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind studyA Cappiello, C J McDougle, R T Malison, et al.
The American Journal of Drug and Alcohol Abuse|January 1, 1992
Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?J H Krystal, L H Price, C Opsahl, et al.
Archives of General Psychiatry|August 2, 2000
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorderC J McDougle, C N Epperson, G H Pelton, et al.
The Journal of Clinical Psychiatry|March 13, 1999
Mirtazapine augmentation in the treatment of refractory depressionL L Carpenter, Z Jocic, J M Hall, et al.
Journal of Child and Adolescent Psychopharmacology|July 1, 1997
Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigationE S Brodkin, C J McDougle, S T Naylor, et al.
Journal of Clinical Psychopharmacology|February 24, 1998
Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotoninM Narayan, G Anderson, J Cellar, et al.
Pageof 20